Doctor profile · Federal record
Dr. David Picascia, M.D.
Dermatology Physician (CMS: Dermatology) · Freehold, NJ
- NPI 1306865613
- Accepts Medicare
- MIPS 83.9 / 100 · 2023
- 44 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
77 Schanck RD, Suite B-3
Freehold, NJ 077282964
(732) 462-9800
fax (732) 308-1647 - Mailing address
-
7 Raintree CT
Holmdel, NJ 077332814
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New Jersey #MA51607
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306865613. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,262
Distinct HCPCS
10
Medicare allowed
$392,505
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,155 | 485 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,141 | 884 | $96 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,136 | 839 | $67 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 590 | 492 | $60 | |
17110 |
Destruction of skin growth, 1-14 growths | 481 | 407 | $125 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 207 | 207 | $119 | |
11102 |
Biopsy of related skin growth, first growth | 189 | 180 | $110 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 182 | 21 | $132 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 122 | 122 | $78 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 33 | 26 | $186 |
In context: peer comparison
Among 3 peers in Freehold Dermatology Physician, average services per provider: 418. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$1,422
Transactions
86
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, INC. | 22 | $323.61 | |
| Novartis Pharmaceuticals Corporation | 12 | $246.47 | |
| Pfizer INC. | 13 | $212.63 | |
| Abbvie INC. | 15 | $198.58 | |
| Arcutis Biotherapeutics, INC. | 7 | $112.17 | |
| Incyte Corporation | 2 | $91.35 | |
| Amgen INC. | 5 | $82.26 | |
| Janssen Biotech, INC. | 4 | $61.24 | |
| Sun Pharmaceutical Industries INC. | 3 | $45.72 | |
| Lilly USA, LLC | 1 | $18.15 | |
| Regeneron Healthcare Solutions, INC. | 1 | $15.79 | |
| Galderma Laboratories, L.P. | 1 | $14.32 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
967
Patients
605
Total drug cost
$144,168
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 205 | 143 | $2,215 |
| Mupirocin | Generic | 134 | 101 | $1,031 |
| Ketoconazole | Generic | 133 | 60 | $2,512 |
| Hydrocortisone | Generic | 113 | 77 | $1,220 |
| Clobetasol Propionate | Generic | 94 | 75 | $4,105 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 69 | 38 | $1,684 |
| Doxycycline Hyclate | Generic | 36 | 17 | $758 |
| Hydroxyzine Hcl | Generic | 26 | 0 | $209 |
| Otezla (Apremilast) | Brand | 25 | 0 | $121,945 |
| Metronidazole | Generic | 24 | 18 | $1,529 |
Frequently asked questions
What is Dr. David Picascia's medical specialty?
Dr. David Picascia practices Dermatology Physician in Freehold, NJ.
Where does Dr. David Picascia practice?
Dr. David Picascia practices at 77 Schanck RD, Freehold, NJ 077282964. Office phone: 7324629800.
What is Dr. David Picascia's NPI?
Dr. David Picascia's National Provider Identifier (NPI) is 1306865613, issued by NPPES.
Does Dr. David Picascia accept Medicare assignment?
Yes. Dr. David Picascia accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Picascia commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.